BBC: Dark web drugs raid leads to 179 arrests

BBC: Dark web drugs raid leads to 179 arrests. “Police forces around the world have seized more than $6.5m (£5m) in cash and virtual currencies, as well as drugs and guns in a co-ordinated raid on dark web marketplaces. Some 179 people were arrested across Europe and the US, and 500kg (1,102lb) of drugs and 64 guns confiscated.”

ABC News (Australia): Social media has provided a new marketplace for drugs and police are struggling to keep up

ABC News (Australia): Social media has provided a new marketplace for drugs and police are struggling to keep up. “With so many in lockdown because of coronavirus, or with limited access to clubs and parties where small quantities of drugs are traditionally traded, selling drugs has become more digitised than ever. And social media is the perfect forum. The internet is embraced by dealers, and buyers, for its simplicity and global reach. But while large drug trading websites like Dream Market or Silk Road have been shut down by law enforcement, social media has emerged as a flourishing new marketplace made up of thousands of small-time dealers who sell tiny amounts of drugs to individual users.”

University of Texas at Austin: Dry powder inhalation could be a potent tool in COVID-19 antiviral treatment

University of Texas at Austin: Dry powder inhalation could be a potent tool in COVID-19 antiviral treatment. “The only antiviral drug currently used to treat SARS-CoV-2, the coronavirus that causes COVID-19, is remdesivir, but administering it is invasive and challenging. Scientists at The University of Texas at Austin are hoping to change that by using their novel thin-film-freezing technology to deliver remdesivir through dry powder inhalation, potentially making treatment more potent, easier to administer and more broadly available.”

Reuters: Becton Dickinson’s rapid antigen test for COVID-19 authorized by FDA, shares rise

Reuters: Becton Dickinson’s rapid antigen test for COVID-19 authorized by FDA, shares rise. “The U.S. Food and Drug Administration has granted emergency use authorization to Becton Dickinson and Co (BDX.N) for a COVID-19 antigen test that can be administered at the point of care and produce results within 15 minutes, the company said on Monday.”

WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls (World Health Organization)

World Health Organization: WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls. “Seventy-three countries have warned that they are at risk of stock-outs of antiretroviral (ARV) medicines as a result of the COVID-19 pandemic, according to a new WHO survey conducted ahead of the International AIDS Society’s biannual conference. Twenty-four countries reported having either a critically low stock of ARVs or disruptions in the supply of these life-saving medicines.”

India coronavirus: Life-saving Covid-19 drugs sold on Delhi black market (BBC)

BBC: India coronavirus: Life-saving Covid-19 drugs sold on Delhi black market. “A BBC investigation has found that two life-saving drugs used to treat Covid-19 patients in India – remdesivir and tocilizumab – are in short supply and being sold for excessive rates on a thriving black market. Vikas Pandey reports from the capital Delhi.”

Coronavirus: US buys nearly all of Gilead’s Covid-19 drug remdesivir (BBC)

BBC: Coronavirus: US buys nearly all of Gilead’s Covid-19 drug remdesivir. “The US is buying nearly all the next three months’ projected production of Covid-19 treatment remdesivir from US manufacturer Gilead. The US health department announced on Tuesday it had agreed to buy 500,000 doses for use in American hospitals.”

NBC News: FDA pulls emergency use authorization of hydroxychloroquine for COVID-19

NBC News: FDA pulls emergency use authorization of hydroxychloroquine for COVID-19. “The Food and Drug Administration rescinded the emergency use authorization for hydroxychloroquine to treat hospitalized COVID-19 patients on Monday, saying the drug carries too many risks without any apparent benefit. The authorization was first issued in March, and applied to patients hospitalized with the illness and those in clinical trials. In April, the FDA warned doctors against prescribing the drug to COVID-19 patients outside of those settings. Monday’s action will not affect clinical trials, which are expected to continue.”

BBC: Dexamethasone is a first life-saving coronavirus drug

BBC: Dexamethasone is a first life-saving coronavirus drug. “A cheap and widely available drug called dexamethasone can help save the lives of patients who are seriously ill with coronavirus. UK experts say the low-dose steroid treatment is major breakthrough in the fight against the deadly virus. It cut the risk of death by a third for patients on ventilators. For those on oxygen, it cut deaths by a fifth.”

NIH: NIH-funded study to evaluate drugs prescribed to children with COVID-19

NIH: NIH-funded study to evaluate drugs prescribed to children with COVID-19. “Researchers funded by the National Institutes of Health have launched an effort to evaluate drugs prescribed to treat COVID-19 in infants, children and adolescents across the country. The study leverages an existing clinical trial that examines drugs that are prescribed off-label to children for a variety of medical conditions. Because many drugs have not been tested specifically for use in children, physicians will often prescribe drugs off-label to children because they lack an alternative, approved treatment.”

Politico: Florida ordered 1M doses of a Trump-touted drug. Hospitals didn’t want it

Politico: Florida ordered 1M doses of a Trump-touted drug. Hospitals didn’t want it. “Florida is sitting on more than 980,000 unused doses of hydroxychloroquine, a drug President Donald Trump touted as a ‘game changer’ in the fight against the coronavirus, after only a handful of hospitals in the state asked for access to the medicine.”

CNN: The US government’s supply of Covid-19 drug remdesivir runs out at the end of the month

CNN: The US government’s supply of Covid-19 drug remdesivir runs out at the end of the month. “The US government’s current supply of remdesivir, the only drug known to work against Covid-19, will run out at the end of the month, Dr. Robert Kadlec, a US Department of Health and Human Services official, told CNN. The government’s last shipment of the drug will go out the week of June 29. Gilead Sciences, the company that makes the drug, is ramping up to make more, but it’s unclear how much will be available this summer.”

The Daily Pennsylvanian: Penn Med professor leads research team on repurposing drugs for COVID-19 treatment

The Daily Pennsylvanian: Penn Med professor leads research team on repurposing drugs for COVID-19 treatment. “Penn researchers are studying how drugs that are typically prescribed for other diseases may also be used to treat coronavirus patients. Perelman School of Medicine Assistant Professor of Medicine David Fajgenbaum, who is leading the drug repurposing efforts, said doctors across the world have treated coronavirus patients with over 150 drugs so far. Fajgenbaum said he began studying the effectiveness of these drugs on March 13, with researchers from Penn’s Center for Cytokine Storm Treatment & Laboratory, the Castleman Disease Collaborative Network, which is his independent foundation, and the Medical School.”